Interventional CardiologistsStructural heart diseaseOther

Thoracoscopic Stand-Alone Left Atrial Appendectomy

solaci
solaci
402
0

Original title: Thoracoscopic Stand-Alone Left Atrial Appendectomy for Thromboembolism Prevention in Nonvalvular Atrial Fibrilation. Reference: Toshiya Ohtsuka, et al. J Am Coll Cardiol 201362;2:103-107

Anticoagulation is commonly prescribed as prevention therapy against AF-induced thromboembolism. However, even a correct prescription may result in an unexpected stroke due to cardioembolic stroke. Different left atrial appendectomy techniques and devices are currently being tested to help solve this problem.

This analysis was performed in one single center by one single surgeon and included 30 patients undergoing thoracoscopic appendectomy. All patients had a +10 year history of AF, 52 mm left atrial mean diameter (46-61) and AF

Previous article
DES versus Bare in primary angioplasty at five years. Initial advantage is reducing
Next article
Percutaneous Left Atrial Appendage Closure With the AMPLATZER : a valid alternative when anticoagulation is contraindicated
solaci
solaci

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Dr. Juan Manuel Pérez - 0
Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Dr. Juan Manuel Pérez - 0
Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...